News | November 16, 2021
Pre-diabetes is a much more serious issue in India: Fitterfly
Two out of three people under the age of 40 are at risk of prediabetes
Two out of three people under the age of 40 are at risk of prediabetes
BRIDGE-1 Comprehensive care programme for Type 1 diabetes and to train 400 physicians and benefit over 1000 children
Vakrangee’s distribution network across rural India will help penetrate underserved markets
The group now has 324 approvals and has so far filed over 400 ANDAs
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
A Sanofi R&D executive will join the Gyroscope Clinical Advisory Board to advise on matters related to the development of GT005 for geographic atrophy (GA).
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
Acute therapies continue to report strong growth compared to chronic ones.
Subscribe To Our Newsletter & Stay Updated
